Neuronetics schedules November 4 results for Neuronetics stock

Published on 10/22/2026 at 13:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter results are due before market open on November 4, 2026. Neuronetics stock costs EUR 1.76 at Lang & Schwarz on October 22, 2026.

Reporting date and operating figures

Neuronetics plans third-quarter results for November 4, 2026.
Second-quarter revenue reached USD 41.57 million against a USD 40.17 million consensus estimate.
Neuronetics stock trades at EUR 1.76 at 1:18 p.m. CEST at Lang & Schwarz on October 22, 2026.

STIM, US64131A1051, Illustration mit AI erstellt.

Neuronetics (ISIN US64131A1051) plans to release third-quarter 2026 results before market open on November 4, 2026, putting the next operating update at the center of the stock story. The company was trading at EUR 1.76 at Lang & Schwarz on October 22, 2026, at 1:18 p.m. CEST.

According to Neuronetics on October 21, 2026, the company will also host a conference call at 8:30 a.m. Eastern Time on the same date. The release identifies Neuronetics as a Nasdaq-listed medical technology company combining NeuroStar transcranial magnetic stimulation with direct patient care through its Greenbrook clinic network.

What does November 4 add?

The coming report will show whether the second-quarter revenue improvement continued into the quarter ended September 2026. In the second quarter, revenue reached USD 41.57 million, compared with a USD 40.17 million consensus estimate, a 3.20 percent beat, according to Zacks on August 11, 2026. The adjusted loss was USD 0.05 per share against a USD 0.11 consensus loss, while the prior-year adjusted loss was USD 0.15 per share.

How much do analysts expect?

Valuation expectations remain materially above the euro quote, but they are expressed in the company's Nasdaq trading currency. MarketBeat reported on October 6, 2026, that five brokerages carried a Moderate Buy consensus and an average 12-month target of USD 4.67. The same report listed four buy ratings and one sell rating, leaving profitability as an important test for the next update.

Dates shape the next test

The next substantiated company date is November 4, 2026, for the third-quarter results and conference call. Management's figures on revenue, adjusted earnings and the Greenbrook network will determine whether the second-quarter comparison remains the right operating benchmark.

Euro quote remains intraday

For German-market readers, the euro indication stood at EUR 1.76 at Lang & Schwarz on October 22, 2026 at 1:18 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Neuronetics stock.